Volcon Inc SEC Filings

Supernus has completed its cash/CVR acquisition of Sage Therapeutics (SAGE). The tender offer, priced at $8.50 per share in cash plus one contingent value right (CVR) worth up to an additional $3.50, expired at one minute past 11:59 p.m. ET on 30 Jul 2025 and was not extended. Equiniti Trust Company, acting as depositary, reported that 36,313,509 shares—approximately 58 % of Sage’s outstanding common stock—were validly tendered and not withdrawn, satisfying the offer’s minimum condition. All tendered shares were irrevocably accepted for payment and will be settled promptly in accordance with the Merger Agreement.

On 31 Jul 2025, immediately after the offer closing, Purchaser was merged into Sage under DGCL §251(h), making Sage a wholly owned subsidiary of Supernus. As a consequence, Sage’s common stock will be delisted from the Nasdaq Global Market and deregistered under the Exchange Act.

• Tender consideration: $8.50 cash + CVR (up to $3.50).
• Shares tendered: 36.3 M (≈58 % of total outstanding).
• Offer expiration: 30 Jul 2025; merger completion: 31 Jul 2025.

All other disclosures in the original Schedule 14D-9 remain unchanged.

Volcon, Inc. (VLCN) – Form 4 insider activity

• Reporting person: Brett S. Director, VP of Legal & Director.
• Purchased 10,000 common shares on 21-Jul-2025 at $10 each in the company’s private placement, bringing direct stock ownership to 10,000 shares.
• Granted 298,802 non-qualified stock options on 17-Jul-2025, exercisable at $10 and expiring 17-Jul-2035. Vesting is performance-based: 20% vests at VWAP ≥ $10, with additional 20% increments until fully vested at VWAP ≥ $30.

The cash purchase (≈ $100k) signals personal commitment, while the long-dated, performance-linked option grant aligns the executive’s incentives with shareholders under Nasdaq Rule 5635(c). Total beneficial ownership after the transactions is 10,000 shares plus 298,802 options.

Volcon, Inc. (Nasdaq: VLCN) has filed a Rule 424(b)(5) prospectus supplement for an “at-the-market” (ATM) program of up to $1.0 billion in common stock. Sales will be made through or to Aegis Capital Corp., which will receive a 1.0% commission and be deemed an underwriter. At the 25 Jul 2025 closing price of $13.40, Volcon could issue about 74.6 million new shares, raising roughly $990 million net after fees and lifting total shares outstanding from 47.4 million to a potential 128.8 million (authorised: 250 million).

Use of proceeds: management “intends” to deploy most of the cash to purchase additional Bitcoin and possibly other digital assets, with the balance for general corporate purposes. No minimum amount is required to be sold and funds will not be placed in escrow.

Key investor considerations

• Dilution: adjusted book value would rise to $12.24 per share, but buyers at $13.40 would face immediate $1.16 dilution; existing shareholders face ~170% potential share count increase.
• Risk profile: Bitcoin price volatility, discretionary use of funds, no dividend policy and a going-concern explanatory paragraph from MaloneBailey, LLP heighten risk.
• Status: Company is an emerging growth & smaller reporting company, enabling lighter disclosure obligations.

There is no obligation for Aegis to sell a specific dollar amount, and Volcon may suspend or terminate the program at any time.

PodcastOne, Inc. (NASDAQ: PODC) filed a Form 8-K dated 30 Jul 2025 to report that it furnished a press release (Exhibit 99.1) containing preliminary, unaudited results for the quarter ended 30 Jun 2025. Management notes that the figures, which are not included in the filing, are based on information available to date, remain subject to final closing procedures and may change. The estimates have not been audited, reviewed or compiled by the company’s independent accounting firm, Macias Gini & O’Connell LLP, and investors are cautioned against undue reliance until GAAP financial statements are released. The disclosure is furnished under Items 2.02 and 7.01 and is expressly not deemed “filed” for Exchange Act liability purposes.

Volcon, Inc. (VLCN) – Form 4 insider filing

Chief Operating Officer Timothy J. Silver disclosed two equity transactions:

• Common stock purchase: 2,500 shares acquired at $10.00 per share in Volcon’s private placement that closed on 21 Jul 2025. Silver now directly owns 2,500 common shares.
• Performance-based stock options: 597,604 non-qualified options granted 17 Jul 2025 with a $10.00 exercise price and 17 Jul 2035 expiry. Vesting is tied to the company’s daily VWAP—20 % at $10, then additional 20 % increments until fully vested at a $30 VWAP.

The option grant was issued as a material inducement to Silver’s employment under Nasdaq Listing Rule 5635(c), aligning executive incentives with share-price appreciation while adding potential future dilution.

ASP Isotopes Inc. (NASDAQ: ASPI) filed an 8-K dated July 25 2025 reporting that the Competition Commission of South Africa has conditionally approved ASPI’s offer to acquire all issued ordinary shares of Renergen Limited. The decision removes a key antitrust obstacle, but closing remains subject to unspecified conditions outlined by the regulator. No purchase price, financing details, or closing timetable are disclosed in the filing.

The related press release is furnished as Exhibit 99.1 (excluding its 5th and 6th paragraphs). No financial statements or earnings updates accompany this report.

Global Mofy AI Limited (GMM) reports the full resolution of its April-2025 PIPE warrants. Purchasers first surrendered 25 % (≈2.55 m) of the 10.20 m warrants, leaving 7.65 m outstanding. Between 8-21 July 2025, those remaining warrants were fully exercised via the 0.8× cashless alternative, converting into 6,117,316 Class A ordinary shares. Because the exercise was cashless, the company received no incremental cash.

Following the issuance, share count stands at 25,495,761 Class A and 3,723,975 Class B shares. The new shares—about 24 % of the current Class A total—are registered under the effective Form F-1 (333-287230). This Form 6-K is also incorporated by reference into the company’s Form F-3 shelf (333-284554).

The update removes a sizeable derivative overhang, simplifying the capital structure, but simultaneously dilutes existing holders without providing fresh capital. No financial results, cash-flow data, or guidance were disclosed.